Is it safe?
Can EW take a bad year?
Edwards Lifesciences holds $3.65B more cash than debt, so a bad year is a question about profits, not about lenders.
$3.65B
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Altman Z-score
- 11.91
Altman Z-score · safe zone, above 3
- Debt / equity
- 0.06×
Debt / equity
Details›
- Total debtQ2 2026
- $599M
- Cash and short-term investments
- $4.25B
- Net cash
- $3.65B
- EBITDA, trailing twelve months
- $1.61B
- Operating profit, trailing twelve months
- $1.45B
- Debt / equity
- 0.06×
- Total debt / EBITDA
- 0.37×
- Annualised volatilitytwo years of daily moves
- 26%
- Worst drawdown on file
- −54%
- Below its 52-week high
- −3.1%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Medical Devices
Ranks #18 of 35 by Smart Score